ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.973,18
-0,57%
S&P 500
5.748,00
-0,50%
Dow Jones
42.615,92
0,07%
Euro vs US Dollar
1,07885
0,02%
Bitcoin
86.683,27
-0,89%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Rhythm Pharmaceuticals Inc (RYTM) Börsenkurse

Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Inc (RYTM)

NASDAQ
53,61
0,70
( 1,32% )
Aktualisiert: 16:15:14
Verzögert um 15 Minuten
Fortg. Diagramm

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
53,61
Gebot
53,43
Fragen
53,70
Volumen
79.189
52,535 Tagesbereich 54,90
35,17 52-Wochen-Bereich 68,58
Marktkapitalisierung
3,389B
Handelsende
52,91
Handelsbeginn
52,89
Letzte Trade
6
@
53.393
Letzter Handelszeitpunkt
16:15:22
Finanzvolumen
US$ 4.220.386
VWAP
53,2951
Durchschnittliches Volumen (3 Mio.)
513.334
Ausgegebene Aktien
63.223.727
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-12,65
Gewinn pro Aktie (EPS)
-4,18
Erlöse
130,13M
Nettogewinn
-264,57M

Über Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanot... Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.rhythmtx.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Rhythm Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RYTM. The last closing price for Rhythm Pharmaceuticals was US$52,91. Over the last year, Rhythm Pharmaceuticals shares have traded in a share price range of US$ 35,17 to US$ 68,58.

Rhythm Pharmaceuticals currently has 63.223.727 shares in issue. The market capitalisation of Rhythm Pharmaceuticals is US$3,35 billion. Rhythm Pharmaceuticals has a price to earnings ratio (PE ratio) of -12.65.

Option-Flow Rhythm Pharmaceuticals (RYTM)

Vollständigen Option-Flow anzeigen

Gesamtfluss

Bullisch

Nettoprämie

26k

Calls / Puts

200,00%

Käuf. / Verkä.

100,00%

OTM / ITM

100,00%

Sweeps

0,00%

RYTM Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report
Edgar (US Regulatory)
20 März 2025
RYTM (1,32%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 März 2025
RYTM (1,32%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
14 März 2025
RYTM (1,32%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
28 Februar 2025
RYTM (1,32%)

Form 8-K - Current report
Edgar (US Regulatory)
28 Februar 2025
RYTM (1,32%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
28 Februar 2025
RYTM (1,32%)

Form 8-K - Current report
Edgar (US Regulatory)
26 Februar 2025
RYTM (1,32%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
11.362.602870813452.2555.8751.8760104353.5501035CS
41.132.1532012195152.4855.8747.8655666852.36548159CS
12-2.925-5.1737861501756.53562.1447.8651333455.21231965CS
260.520.97946882652153.0968.5846.850883356.232125CS
5213.6634.192740926239.9568.5835.1750764249.87561482CS
15641.53343.79139072812.0868.583.0479159927.02344146CS
26038.92264.94213750914.6968.583.0461670425.16981569CS

RYTM - Frequently Asked Questions (FAQ)

What is the current Rhythm Pharmaceuticals share price?
The current share price of Rhythm Pharmaceuticals is US$ 53,61
How many Rhythm Pharmaceuticals shares are in issue?
Rhythm Pharmaceuticals has 63.223.727 shares in issue
What is the market cap of Rhythm Pharmaceuticals?
The market capitalisation of Rhythm Pharmaceuticals is USD 3,35B
What is the 1 year trading range for Rhythm Pharmaceuticals share price?
Rhythm Pharmaceuticals has traded in the range of US$ 35,17 to US$ 68,58 during the past year
What is the PE ratio of Rhythm Pharmaceuticals?
The price to earnings ratio of Rhythm Pharmaceuticals is -12,65
What is the cash to sales ratio of Rhythm Pharmaceuticals?
The cash to sales ratio of Rhythm Pharmaceuticals is 25,73
What is the reporting currency for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Rhythm Pharmaceuticals?
The latest annual turnover of Rhythm Pharmaceuticals is USD 130,13M
What is the latest annual profit for Rhythm Pharmaceuticals?
The latest annual profit of Rhythm Pharmaceuticals is USD -264,57M
What is the registered address of Rhythm Pharmaceuticals?
The registered address for Rhythm Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Rhythm Pharmaceuticals website address?
The website address for Rhythm Pharmaceuticals is www.rhythmtx.com
Which industry sector does Rhythm Pharmaceuticals operate in?
Rhythm Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PTPIPetros Pharmaceuticals Inc
US$ 0,1601
(176,99%)
798,12M
OSRHOSR Holdings Inc
US$ 3,125
(95,31%)
59,48M
VVPRVivoPower International PLC
US$ 4,41
(95,13%)
106,1M
SURGSurgePays Inc
US$ 2,365
(71,38%)
56,49M
AQBAquaBounty Technologies Inc
US$ 0,969299
(43,24%)
32,04M
BACKIMAC Holdings Inc
US$ 0,081
(-59,50%)
904,24k
ACRVAcrivon Therapeutics Inc
US$ 3,365
(-37,57%)
690,94k
TNONTenon Medical Inc
US$ 2,63
(-29,87%)
14,41M
ICGIntchains Group Ltd
US$ 2,90
(-29,61%)
96,77k
HUMAHumacyte Inc
US$ 2,035
(-29,22%)
12,59M
PTPIPetros Pharmaceuticals Inc
US$ 0,1601
(176,99%)
798,12M
OCEAOcean Biomedical Inc
US$ 0,08055
(41,81%)
211,19M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,0611
(20,75%)
136,4M
NVDANVIDIA Corporation
US$ 115,38
(-4,40%)
115,52M
VVPRVivoPower International PLC
US$ 4,41
(95,13%)
106,1M

RYTM Finanzen

Finanzen

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
RYTM
Rhythm Pharmaceuticals
USOTC
KHTRF
Knight Therapeutics (PK)
USOTC
LKFLF
Luk Fook (PK)
BIT
UB7HQT
Unicredit Bank
BIT
LATAM
Exchange Traded
BIT
P1R9X5
BNP Paribas Issuance
USOTC
NZSTF
NZX (PK)
USOTC
GXXFF
Gold Basin Resources (QB)
USOTC
SFHLF
SAF Holland (PK)
USOTC
SSILF
SA SA International Holdings Ltd
USOTC
KBGGY
Kongsberg Gruppen ASA (PK)
USOTC
KPGHF
Kelly Partners (QX)
BIT
BUND3L
Solactive leveraged long...
BIT
P1ILQ7
BNP Paribas Issuance
USOTC
CHAG
Chancellor (CE)
BIT
UC59WF
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten